Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients?

AIDS Behav. 2016 May;20(5):1108-15. doi: 10.1007/s10461-015-1231-7.

Abstract

This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication ("Are you still taking the Combivir?"); (2) broad ("How's it going with your meds?"); (3) positively-framed ("Are you taking your medications regularly?"); (4) negatively-framed ("Have you missed any doses?"). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses.

Keywords: Adherence; Antiretrovirals; HIV/AIDS; Physician-patient communication.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Attitude of Health Personnel
  • Communication*
  • Disclosure*
  • Drug Combinations
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / psychology
  • Humans
  • Interviews as Topic
  • Lamivudine / therapeutic use
  • Male
  • Medication Adherence / statistics & numerical data*
  • Middle Aged
  • Office Visits
  • Patient Care
  • Physician-Patient Relations*
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • lamivudine, zidovudine drug combination
  • Lamivudine
  • Zidovudine